Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
04:16pm, Wednesday, 08'th May 2024
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 01'st May 2024
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
01:00am, Thursday, 25'th Apr 2024
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT.
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
01:45pm, Wednesday, 24'th Apr 2024
Investing in discounted stocks for big gains is a time-tested strategy. Although short-term market fluctuations may capture the attention of many, companies with sustainable growth prospects often pro
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
08:00am, Monday, 22'nd Apr 2024
The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET
Jim Cramer lays out his top small-cap healthcare picks
08:29pm, Friday, 05'th Apr 2024
'Mad Money' host Jim Cramer shares his small-cap healthcare stock picks.
Jim Cramer recommends five small-cap health-care stocks
06:51pm, Friday, 05'th Apr 2024
CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.
Why Is Catalyst (CPRX) Down 0.6% Since Last Earnings Report?
12:37pm, Friday, 29'th Mar 2024
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
08:03am, Thursday, 28'th Mar 2024
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
08:03am, Wednesday, 27'th Mar 2024
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
07:44am, Wednesday, 27'th Mar 2024
Biotech has seen its fair share of ups and downs, including a massive surge during the pandemic followed by a considerable dip. However, the industry will never go too far away from center stage as di
7 Biotech Stocks Ready to Ride the Sector's Resurgence
08:01pm, Monday, 18'th Mar 2024
Why do you want to consider biotech stocks? Simply, the narrative comes down to numbers and a possible rotation.
Santhera's Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
02:00am, Thursday, 14'th Mar 2024
Pratteln, Switzerland, March 14, 2024 – Santhera Pharmaceuticals (SIX: SANN) is pleased to note the launch of AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) in the Un
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
07:55am, Wednesday, 13'th Mar 2024
AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile
3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio
03:24pm, Sunday, 10'th Mar 2024
If you want big returns, you gotta think small – as in small-cap stocks. That's not to say the large-capitalization enterprises can't get you to investment Valhalla.
